Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

PRANAV R MEHTA

Allopathic & Osteopathic Physicians Family Medicine

NPI
1467527762
CMS profile
404693
Location
YUCAIPA, CA

General Payments · PY2018–2024

$2,198.66

  • Reported across 119 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$351.86

13 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $351.86 13

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $182.58 3
Abbott Laboratories $85.17 5
Boehringer Ingelheim Pharmaceuticals, Inc. $25.84 1
ABBVIE INC. $17.09 1
Inspire Medical Systems, Inc. $14.18 1
PFIZER INC. $13.84 1
Novo Nordisk AS $13.16 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $51.46 4
PY2019 $246.10 7
PY2020 $333.31 18
PY2021 $465.12 35
PY2022 $473.92 26
PY2023 $276.89 16
PY2024 $351.86 13

Payment records · PY2024 (13)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $19.01 02/23/2024 Food and Beverage Undisputed 01/23/2026 1125079169 CMS
Abbott Laboratories $19.48 05/30/2024 Food and Beverage Undisputed 01/23/2026 1125079171 CMS
Abbott Laboratories $16.23 07/03/2024 Food and Beverage Undisputed 01/23/2026 1125079173 CMS
Abbott Laboratories $16.06 07/26/2024 Food and Beverage Undisputed 01/23/2026 1125079175 CMS
Abbott Laboratories $14.39 10/25/2024 Food and Beverage Undisputed 01/23/2026 1125079177 CMS
ABBVIE INC. $17.09 03/26/2024 Food and Beverage Undisputed 01/23/2026 1105016600 CMS
AstraZeneca Pharmaceuticals LP $142.63 01/16/2024 Food and Beverage Undisputed 01/23/2026 1105701304 CMS
AstraZeneca Pharmaceuticals LP $18.07 05/01/2024 Food and Beverage Undisputed 01/23/2026 1105340816 CMS
AstraZeneca Pharmaceuticals LP $21.88 08/14/2024 Food and Beverage Undisputed 01/23/2026 1105645572 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $25.84 10/23/2024 Food and Beverage Undisputed 01/23/2026 1118021320 CMS
Inspire Medical Systems, Inc. $14.18 03/13/2024 Food and Beverage Undisputed 01/23/2026 1148082127 CMS
Novo Nordisk Inc $13.16 08/30/2024 Food and Beverage Undisputed 01/23/2026 1097192933 CMS
PFIZER INC. $13.84 08/06/2024 Food and Beverage Undisputed 01/23/2026 1131874543 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.